Influence of HLA-C matching on aGvHD of unrelated and family donor hematopoietic stem cell transplantation in pediatric patients with hematologic malignancies.

被引：0
|
作者：
Enczmann, J
Meisel, R
Ogrzewalla, K
Kögler, G
Laws, HJ
Kramm, C
Bernbeck, B
Tröger, A
Wernet, P
Göbel, U
Dilloo, D
机构：
[1] Univ Hosp, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany
[2] Univ Hosp, Clin Pediat Oncol Hematol & Immunol, Dusseldorf, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5465
引用
收藏
页码：454B / 454B
页数：1
相关论文
共 50 条
  • [41] Unrelated and Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Using TCR αβ+CD3+Depletion in Pediatric Patients with Hematologic Malignancies
    Freedman, Jason L.
    Wang, Yongping
    Monos, Dimitri S.
    Li, Yimei
    Barrett, David M.
    Olson, Timothy S.
    Seif, Alix E.
    Teachey, David T.
    Grupp, Stephan A.
    Bunin, Nancy J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S244 - S245
  • [42] HLA-C*07:02:60, a variant of HLA-C*07 found in an unrelated volunteer stem cell donor
    Testi, M.
    Andreani, M.
    Galluccio, T.
    Guagnano, A.
    Paladini, E.
    TISSUE ANTIGENS, 2015, 85 (01): : 77 - +
  • [43] Detection of HLA-C*08:147, an HLA-C*08 variant, in a Taiwanese hematopoietic stem cell donor
    Yang, Kuo-Liang
    Lin, Py-Yu
    HLA, 2019, 93 (04) : 237 - +
  • [44] Oral mucositis (OM) and outcomes of allogeneic (AL) hematopoietic stem cell transplantation (HSCT) in patients with hematologic malignancies.
    Vera-Lionch, M
    Oster, G
    Ford, C
    Lu, J
    Khazanov, I
    Sonis, S
    BLOOD, 2005, 106 (11) : 874A - 875A
  • [45] Effect of impaired renal function on the outcome of submyeloablative allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
    Mehta, J
    Cetiner, M
    Gordon, L
    Evens, A
    Tallman, M
    Williams, S
    Winter, J
    Meagher, R
    Singhal, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 601S - 601S
  • [46] Both Optimal Matching and Procedure Duration Influence Survival of Patients after Unrelated Donor Hematopoietic Stem Cell Transplantation
    Mizia, Sylwia
    Dera-Joachimiak, Dorota
    Polak, Malgorzata
    Koscinska, Katarzyna
    Sedzimirska, Mariola
    Lange, Andrzej
    BONE MARROW RESEARCH, 2012,
  • [47] The impact of HLA-A*01:01/HLA-A*03:01 genotype on the results of unrelated allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies
    Kuzmina, L.
    Parovichnikova, E.
    Vasilyeva, V.
    Sorokina, T.
    Biderman, B.
    Yakutik, I.
    Khamaganova, E.
    Drokov, M.
    Mikhaltsova, E.
    Koroleva, O.
    Dubnyak, D.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S145 - S145
  • [48] Non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from a family donor based on feto-maternal microchimerism in pediatric hematological malignancies.
    Yoshihara, T
    Morimoto, A
    Ishida, H
    Kuroda, H
    Maruya, E
    Imashuku, S
    BLOOD, 2003, 102 (11) : 485A - 486A
  • [49] The influence of molecular HLA-C typing on matching in HLA-A,B,DRB*1 identical unrelated bone marrow donor transplantation
    Wolpl, A
    Eirmann, T
    Loffler, D
    Kaltenbacher, U
    Goldmann, S
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P448 - P448
  • [50] Association of HLA matching with reduced relapse rate in unrelated allogeneic hematopoietic stem cell transplantation for various hematological malignancies
    Kawase, T.
    Kashiwase, K.
    Saji, H.
    Inoko, H.
    Kodera, Y.
    Sasazuki, T.
    Yasuo, M.
    TISSUE ANTIGENS, 2008, 72 (03): : 291 - 292
12345